Evidence for an Intramacrophage Growth Phase ofMycobacterium ulcerans
- 1 February 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (2) , 977-987
- https://doi.org/10.1128/iai.00889-06
Abstract
Mycobacterium ulcerans is the etiologic agent of Buruli ulcer (BU), an emerging tropical skin disease. Virulent M. ulcerans secretes mycolactone, a cytotoxic exotoxin with a key pathogenic role. M. ulcerans in biopsy specimens has been described as an extracellular bacillus. In vitro assays have suggested a mycolactone-induced inhibition of M. ulcerans uptake by macrophages in which its proliferation has not been demonstrated. Therefore, and uniquely for a mycobacterium, M. ulcerans has been classified as an extracellular pathogen. In specimens from patients and in mouse footpad lesions, extracellular bacilli were concentrated in central necrotic acellular areas; however, we found bacilli within macrophages in surrounding inflammatory infiltrates. We demonstrated that mycolactone-producing M. ulcerans isolates are efficiently phagocytosed by murine macrophages, indicating that the extracellular location of M. ulcerans is not a result of inhibition of phagocytosis. Additionally, we found that M. ulcerans multiplies inside cultured mouse macrophages when low multiplicities of infection are used to prevent early mycolactone-associated cytotoxicity. Following the proliferation phase within macrophages, M. ulcerans induces the lysis of the infected host cells, becoming extracellular. Our data show that M. ulcerans, like M. tuberculosis, is an intracellular parasite with phases of intramacrophage and extracellular multiplication. The occurrence of an intramacrophage phase is in accordance with the development of cell-mediated and delayed-type hypersensitivity responses in BU patients.Keywords
This publication has 100 references indexed in Scilit:
- Cytokine Response to Antigen Stimulation of Whole Blood from Patients with Mycobacterium ulcerans Disease Compared to That from Patients with TuberculosisClinical and Vaccine Immunology, 2006
- Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real‐time PCR quantification of mycobacterial DNAThe Journal of Pathology, 2005
- A Newly Discovered Mycobacterial Pathogen Isolated from Laboratory Colonies of Xenopus Species with Lethal Infections Produces a Novel Form of Mycolactone, the Mycobacterium ulcerans Macrolide ToxinInfection and Immunity, 2005
- A Novel Mycolactone from a Clinical Isolate of Mycobacterium ulcerans Provides Evidence for Additional Toxin Heterogeneity as a Result of Specific Changes in the Modular Polyketide SynthaseChemBioChem, 2005
- Cytokine Responses to Stimulation of Whole Blood from Patients with Buruli Ulcer Disease in GhanaClinical and Vaccine Immunology, 2005
- SWR Mice Are Highly Susceptible to Pulmonary Infection with Mycobacterium tuberculosisInfection and Immunity, 2003
- Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection.Journal of Clinical Pathology, 1993
- Host and bacterial factors control theMycobacterium avium-induced chronic peritoneal granulocytosis in miceClinical and Experimental Immunology, 1991
- Immunosuppressive Properties of the Soluble Toxin from Mycobacterium ulceransThe Journal of Infectious Diseases, 1988
- Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skinArchives of Dermatology, 1974